Validating a depression screening tool for new fathers in France
Validation of the French Version of the Edinburgh Postnatal Depression Scale (EPDS) Postnatally in the Father
This study is testing a French version of a depression questionnaire for new dads to see if it can help identify those who might be struggling with postnatal depression.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | Groupe Hospitalier du Havre Academic / other |
| Locations | 2 sites (Clamart and 1 other locations) |
| Trial ID | NCT06772701 on ClinicalTrials.gov |
What this trial studies
This study aims to validate the French version of the Edinburgh Postnatal Depression Scale (EPDS) for screening postnatal depression in fathers. As fatherhood evolves, it is crucial to recognize that men can also experience significant psychological challenges during the perinatal period. The study will involve administering the EPDS to fathers of newborns aged 10 days or less to assess its effectiveness as a screening tool. By validating this scale, the research seeks to improve early detection and treatment of postnatal depression in men.
Who should consider this trial
Good fit: Ideal candidates for this study are fathers whose babies are 10 days old or less.
Not a fit: Patients who may not benefit from this study include those with a poor understanding of spoken or written French, minors, or individuals under legal protection.
Why it matters
Potential benefit: If successful, this study could lead to better identification and management of postnatal depression in fathers, ultimately improving their mental health and family dynamics.
How similar studies have performed: While the EPDS is widely used for women, its validation for men is less established, making this approach novel and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All fathers whose baby is 10 days old or less Exclusion Criteria: * People with a poor understanding of spoken or written French * Minors * Persons under court protection, guardianship or curatorship
Where this trial is running
Clamart and 1 other locations
- Antoine-Béclère hospital AP-HP — Clamart, France (Enrolling_by_invitation)
- Le Havre hospital - site Jacques Monod — Montivilliers, France (Recruiting)
Study contacts
- Study coordinator: Angélique PICARD, project coordinator
- Email: angelique.picard@ch-havre.fr
- Phone: +33232734856
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.